RERobert H. Eckel

Robert H. Eckel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert H. Eckel has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Dalan R Jensen

    2 shared publications
  • Gary K Grunwald

    From the Division of Endocrinology, Metabolism, and Diabetes (RHE, TLH, KMW, and TYS), the Department of Preventive Medicine and Biometrics (MLB and GKG), the Department of Pediatrics, Center for Human Nutrition (TAS and JOH), and the Adult General Clinical Research Center (CCF), University of Colorado at Denver and Health Sciences Center, Denver, CO

    2 shared publications
  • Isabel R. Schlaepfer

    Division of Endocrinology, Metabolism and Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, CO, USA

    2 shared publications
  • James O Hill

    From the Division of Endocrinology, Metabolism, and Diabetes (RHE, TLH, KMW, and TYS), the Department of Preventive Medicine and Biometrics (MLB and GKG), the Department of Pediatrics, Center for Human Nutrition (TAS and JOH), and the Adult General Clinical Research Center (CCF), University of Colorado at Denver and Health Sciences Center, Denver, CO

    2 shared publications
  • Kathleen M Weil

    From the Division of Endocrinology, Metabolism, and Diabetes (RHE, TLH, KMW, and TYS), the Department of Preventive Medicine and Biometrics (MLB and GKG), the Department of Pediatrics, Center for Human Nutrition (TAS and JOH), and the Adult General Clinical Research Center (CCF), University of Colorado at Denver and Health Sciences Center, Denver, CO

    2 shared publications
  • Leslie K. Pulawa

    Division of Endocrinology, Metabolism and Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, CO, USA

    2 shared publications

Latest Publications

  • Obesity research in the next decade

    by R H Eckel

    The obesity epidemic demands more insight into genetic predisposition, mechanisms, prevention and therapeutic interventions. Opinions about how to prioritize obesity research in the next decade are many and highly varied. However, in this article I have chosen three areas of focus that arguably should be at the top of the list. These include: (1) the physiologic basis of body weight and body fat regulation; (2) epigenetic mechanisms of energy balance; and (3) the prevention of obesity. The approach needs to be translational and bi-directional with a strong emphasis on basic science including studies of relevant gene expression and animal models of energy balance. Clinical research into mechanisms can challenge the existing paradigms that could direct research back to more basic understanding or to applications to populations at risk. Communication between scientists and physicians at the far end of the spectrum needs new and ongoing emphasis.


  • Open Access

    Skeletal Muscle–Specific Deletion of Lipoprotein Lipase Enhances Insulin Signaling in Skeletal Muscle but Causes Insulin Resistance in Liver and Other Tissues

    by Hong Wang, Leslie A. Knaub, Dalan R. Jensen, Dae Young Jung, Eun-Gyoung Hong, Hwi-Jin Ko, Alison M. Coates, Ira J. Goldberg, Becky A. de la Houssaye, Rachel C. Janssen, et al.

    OBJECTIVE Skeletal muscle–specific LPL knockout mouse (SMLPL−/−) were created to study the systemic impact of reduced lipoprotein lipid delivery in skeletal muscle on insulin sensitivity, body weight, and composition. RESEARCH DESIGN AND METHODS Tissue-specific insulin sensitivity was assessed using a hyperinsulinemic-euglycemic clamp and 2-deoxyglucose uptake. Gene expression and insulin-signaling molecules were compared in skeletal muscle and liver of SMLPL−/− and control mice. RESULTS Nine-week-old SMLPL−/− mice showed no differences in body weight, fat mass, or whole-body insulin sensitivity, but older SMLPL−/− mice had greater weight gain and whole-body insulin resistance. High-fat diet feeding accelerated the development of obesity. In young SMLPL−/− mice, insulin-stimulated glucose uptake was increased 58% in the skeletal muscle, but was reduced in white adipose tissue (WAT) and heart. Insulin action was also diminished in liver: 40% suppression of hepatic glucose production in SMLPL−/− vs. 90% in control mice. Skeletal muscle triglyceride was 38% lower, and insulin-stimulated phosphorylated Akt (Ser473) was twofold greater in SMLPL−/− mice without changes in IRS-1 tyrosine phosphorylation and phosphatidylinositol 3-kinase activity. Hepatic triglyceride and liver X receptor, carbohydrate response element–binding protein, and PEPCK mRNAs were unaffected in SMLPL−/− mice, but peroxisome proliferator–activated receptor (PPAR)-γ coactivator-1α and interleukin-1β mRNAs were higher, and stearoyl–coenzyme A desaturase-1 and PPARγ mRNAs were reduced. CONCLUSIONS LPL deletion in skeletal muscle reduces lipid storage and increases insulin signaling in skeletal muscle without changes in body composition. Moreover, lack of LPL in skeletal muscle results in insulin resistance in other key metabolic tissues and ultimately leads to obesity and systemic insulin resistance.


  • Open Access

    Skeletal muscle munc18c and syntaxin 4 in human obesity

    by Bryan C Bergman, Marc-Andre Cornier, Tracy J Horton, Daniel H Bessesen, Robert H Eckel

    Animal and cell culture data suggest a critical role for Munc18c and Syntaxin 4 proteins in insulin mediated glucose transport in skeletal muscle, but no studies have been published in humans.


  • Nonsurgical Management of Obesity in Adults

    by Robert H. Eckel

    A 44-year-old woman desires weight reduction. She has a history of hypertension, daytime somnolence, and osteoarthritis. Her weight is 215 lb (98 kg), her waist circumference is 40 in. (102 cm), and her body-mass index is 32.7. Her blood pressure is 140/92 mm Hg. What would you advise?


  • Open Access

    Egg consumption in relation to cardiovascular disease and mortality: the story gets more complex

    by Robert H Eckel

    More egg on our faces? It's really hard to say at this point, but it still seems, if you're a middle-aged male physician and enjoy eggs more than once a day, that having some of the egg left on your face may be better than having it go down your gullet. In this issue of the Journal, Djoussé and Gaziano (1) have calculated an adjusted hazard ratio of 1.41 for all-cause mortality over a 20-y span in 21 327 Harvard-educated male physicians who ate ≥1 egg/d. It is important that a pattern of less frequent intake did not influence risk. However, if diabetes was coexistent in these health care professionals, a trend existed across a broader range of egg consumption. The egg intake pattern in this study population was extremely low: only 8% of participants were eating ≥1 egg/d. For comparison, 36% of the men in the Framingham study (2) and 37% of men in a Japanese study (3) with similar outcome assessments ate ≥1 egg/d. However, in both of those other cohorts, there was no association between egg consumption and myocardial infarction, cardiovascular disease (CVD) death, or all-cause mortality. Yet, this much higher consumption pattern may have confounded a graded effect that occurred at lower egg intakes.


  • Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic CVD

    by Robert H. Eckel

    The metabolic syndrome represents a summation of obesity-driven risk factors for atherosclerotic CVD and type 2 diabetes. Definitions of the syndrome vary but in general agree closely in identifying subjects. The relationships between the metabolic syndrome and atherosclerotic CVD and diabetes also vary, with relative risks of approximately 1·5–3·0 and approximately 3·0–5·0 respectively. Insulin resistance appears to explain much of the pathophysiology of the syndrome. Both increased fatty acid flux and an excess of circulating pro-inflammatory cytokines are likely mediators. With increased waist circumference, increases in fatty acid delivery to the liver result in higher rates of hepatic glucose production and increases in the secretion of apoB-containing lipoproteins. Concomitant changes in HDL ensue, including a replacement of the cholesterol content with TAG, an accelerated clearance from the plasma and thus a reduced number of HDL particles. Typically also present are increases in small dense LDL. Hypertension in part relates to the insulin resistance, but may involve other mechanisms. Impaired fasting glucose often relates to defects in insulin secretion in addition to insulin resistance, and probably more than any other component of the syndrome predicts the increased incidence of type 2 diabetes. Although not included in the diagnostic criteria, increases in pro-inflammatory cytokines and pro-thrombotic factors, in addition to decreases in plasma adiponectin, may also contribute to the increased incidence of atherosclerotic CVD and diabetes. In general, the greater the number of metabolic syndrome components, the greater the risk for these outcomes. The cytokines and pro-thrombotic factors also appear to contribute.


  • Treatment of hypertriglyceridemia.

    by Warren H. Capell, Robert H. Eckel


  • Open Access

    Carbohydrate balance predicts weight and fat gain in adults

    by Robert H Eckel, Teri L Hernandez, Melanie L Bell, Kathleen M Weil, Trudy Y Shepard, Gary K Grunwald, Teresa A Sharp, Coni C Francis, James O Hill

    Background: The prevention and treatment of obesity is a public health challenge. Objective: We investigated the effects of dietary composition, insulin sensitivity (SI), and energy balance on predicted changes in body composition. Design: In a randomized crossover design study, 39 normal-weight (n = 23), overweight (n = 8), and obese (n = 8) men and women (aged 25–36 y) each followed a 15-d isocaloric high-fat (HF; 50% fat) and high-carbohydrate [HC; 55% carbohydrate (CHO)] diet with a 4–6-wk washout period during the first year. During each treatment, energy balance was measured while the subjects were inactive by using indirect calorimetry on day 15, and SI was measured by using a euglycemic clamp study (40 mU · m−2 · min−1) on day 16. Weight and body composition were then measured annually for 4 y. The outcomes for fat mass, percentage body fat, and weight were measured by using a linear 2-stage mixed model. Results: CHO balance (day 15) and SI (day 16) on the HC diet were highly and significantly correlated (r = 0.55, P < 0.001). On the HC diet, the subjects who had a higher positive CHO balance (day 15) gained less fat mass (P < 0.001), percentage body fat (P = 0.006), and weight (P = 0.024) over time. When adjusted for SI, CHO balance remained a significant predictor of changes in fat mass (P = 0.021) and percentage body fat (P = 0.025). Conclusions: On a HC diet, the subjects who had a higher positive CHO balance on day 15 while they were inactive gained less fat mass during 4 y, a predictive effect independent of SI. As suggested in rodents, the capacity to expand the glycogen pool might reduce energy intake and protect against fat and weight gain.


  • The metabolic syndrome – Authors' reply

    by Robert Eckel, Scott Grundy, Paul Zimmet